India  

Oxford Covid-19 vaccine may become the first to get Indian regulator's nod for emergency use

IndiaTimes Saturday, 26 December 2020
Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on Covid-19 at the CDSCO will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here, official sources said.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Covid-19: India likely to approve AstraZeneca vaccine for emergency use by next week | Oneindia News

Covid-19: India likely to approve AstraZeneca vaccine for emergency use by next week | Oneindia News 01:09

India is likely to approve Oxford-AstraZeneca coronavirus vaccine for emergency use by next week after Serum Institute of India submitted additional data sought by authorities. This could be the first country to give the regulatory green light for the British drugmaker's covidshield vaccine as the...

💡 newsR Knowledge: Other News Mentions

University of Oxford University of Oxford Collegiate research university in Oxford, England

How big is risk of clots from Covishield?

The risk is extremely low, and the link between blood clots and the Oxford-AstraZeneca vaccine is still not 100% clear. Also, the clots can be treated if..
IndiaTimes

Family of Italian woman who died after Oxford jab launch legal action

The family of an Italian woman who died weeks after having the Oxford-AstraZeneca coronavirus vaccine have told Sky News they are taking legal action to..
Sky News
How do people feel about the AstraZeneca vaccine? [Video]

How do people feel about the AstraZeneca vaccine?

Under-30s in the UK will be offered Pfizer or Moderna vaccines rather than the Oxford/AstraZeneca vaccine due to concerns over a very rare risk of blood clots. The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said there were still huge benefits of the vaccine in preventing Covid-19, and has not concluded that the vaccine causes rare clots, although it says the link is getting firmer. Report by Patelr. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:05Published

Risk of blood clot after COVID is eight times higher than after AstraZeneca jab - study

The risk of developing a blood clot after having COVID-19 is eight times higher than after being given the Oxford-AstraZeneca vaccine, according to a study by..
Sky News

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Amid COVID-19 surge, India to get Remdesivir, oxygen, ISO containers from several countries

India is looking towards its east to Singapore for supplies, and trying to source Oxygen and ISO containers from the South East Asian Country.
DNA
Covid spending pushes deficit to highest levels since Second World War [Video]

Covid spending pushes deficit to highest levels since Second World War

The huge sums that the Government has borrowed during the Covid-19 crisis have pushed the deficit to its highest point since the end of the Second World War, according to new figures.

Credit: PA - Press Association STUDIO    Duration: 00:55Published
Minister says vaccine data is ‘incredibly encouraging’ [Video]

Minister says vaccine data is ‘incredibly encouraging’

Culture minister Caroline Dinenage has praised the Covid vaccine, saying the latest results are "incredibly encouraging". Experts believe that vaccines should be able to control the Covid-19 pandemic, as they published new real-world UK data which shows that jabs slash infections and are likely to cut transmission. Report by Patelr. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:41Published

Char Dham Yatra 2021: Pilgrims need to carry negative RT-PCR report - check other details

In 2019, nearly 38 lakh pilgrims visited the holy shrines, but in 2020, due to the COVID-19 pandemic, only 4.2 lakh could embark only the pilgrimage.
DNA

Central Drugs Standard Control Organisation Central Drugs Standard Control Organisation

Import licences for foreign vaccine in 3 days, says government

“The CDSCO (Central Drugs Standard Control Organisation) will process applications for registration certificate (registration of oversees manufacturing site..
IndiaTimes

Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccines

The Central Drugs Standards Control Organisation (CDSCO) headed by Drugs Controller General of India (DCGI) has explained that it prepare detailed guidelines..
IndiaTimes

You Might Like


Related videos from verified sources

Naples first responders receive COVID-19 vaccine 4 months after one of their colleagues died [Video]

Naples first responders receive COVID-19 vaccine 4 months after one of their colleagues died

Naples first responders receive COVID-19 vaccine 4 months after one of their colleagues died

Credit: FOX 4 Now Florida     Duration: 02:00Published
The COVID-19 vaccine and pregnancy, local OBGYN share recommendations [Video]

The COVID-19 vaccine and pregnancy, local OBGYN share recommendations

With people getting their first doses of COVID-19 vaccines, Many are wondering if the vaccine is safe for certain groups of people.

Credit: KGUN, Tucson, AZ     Duration: 02:30Published
Insider Poll: When Do Most Americans Think They'll Get Vaccinated [Video]

Insider Poll: When Do Most Americans Think They'll Get Vaccinated

According to recent Business Insider polling the typical American believes they will be eligible for a COVID-19 vaccine within the next three months. The CDC recommends that the first round of..

Credit: Wochit Entertainment     Duration: 00:32Published

Related news from verified sources

Oxford Covid-19 vaccine may become the first to get Indian regulator's nod for emergency use

Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on Covid-19 at the CDSCO will hold its meeting and thoroughly review...
IndiaTimes

India's drug regulator to meet again on January 1 to discuss AstraZeneca vaccine

CDSCO, India's drug regulator will meet on Friday to consider approving AstraZeneca and Oxford University's Covid-19 vaccine for emergency use. SII, the world's...
IndiaTimes Also reported by •Hindu

UK approves Pfizer-BioNTech COVID-19 vaccine, will be available from next week

Britain on Wednesday approved the Pfizer-BioNTech COVID-19 vaccine on independent advice of its medicines regulator. The vaccine will be made available across...
Mid-Day Also reported by •Hindu